Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:937-942
Published online before print September 12, 2005, doi: 10.1161/01.HYP.0000175813.04375.8a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/4/937    most recent
01.HYP.0000175813.04375.8av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Castro, C. H.
Right arrow Articles by Pinto de Almeida, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Castro, C. H.
Right arrow Articles by Pinto de Almeida, A.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Coronary circulation
Right arrow ACE/Angiotension receptors

(Hypertension. 2005;46:937.)
© 2005 American Heart Association, Inc.


Part 2 Original Articles

Evidence for a Functional Interaction of the Angiotensin-(1–7) Receptor Mas With AT1 and AT2 Receptors in the Mouse Heart

Carlos Henrique de Castro; Robson Augusto Souza dos Santos; Anderson José Ferreira; Michael Bader; Natalia Alenina; Alvair Pinto de Almeida

From the Departments of Physiology and Biophysics (C.H.C., R.A.S.d.S., A.P.d.A.) and Morphology (A.J.F.), Federal University of Minas Gerais, Belo Horizonte, Brazil, and the Max Delbrück Center for Molecular Medicine (M.B., N.A.), Berlin-Buch, Germany.

Correspondence to Alvair Pinto de Almeida, PhD, Departamento de Fisiologia e Biofísica, Av Antônio Carlos 6627, IC-UFMG 31 270-901, Belo Horizonte, MG, Brazil. E-mail apa{at}icb.ufmg.br

The aim of this study was to evaluate the angiotensin (Ang)-(1–7) effects in isolated mouse hearts. The hearts of male C57BL/6J and knockout mice for the Ang-(1–7) receptor Mas were perfused by the Langendorff method. After a basal period, the hearts were perfused for 20 minutes with Krebs-Ringer solution (KRS) alone (control) or KRS containing Ang-(1–7) (0.22 pmol/L), the Mas antagonist A-779 (115 nmol/L), the angiotensin type 1 receptor antagonist losartan (2.2 µmol/L), or the angiotensin type 2 receptor antagonist PD123319 (130 nmol/L). To evaluate the involvement of Ang receptors, prostaglandins, and nitric oxide in the Ang-(1–7) effects, the hearts were perfused for 20 to 30 minutes with KRS containing either A-779, losartan, PD123319, indomethacin, or NG-nitro-L-arginine methyl ester (L-NAME) alone or in association with subsequent Ang-(1–7) perfusion. In addition, hearts from Mas-knockout mice were perfused for 20 minutes with KRS containing Ang-(1–7) (0.22 pmol/L) and losartan. Ang-(1–7) alone did not change the perfusion pressure. Strikingly, in the presence of losartan, 0.22 pmol/L Ang-(1–7) induced a significant decrease in perfusion pressure, which was blocked by A-779, indomethacin, and L-NAME. Furthermore, this effect was not observed in Mas-knockout mice. In contrast, in the presence of PD123319, Ang-(1–7) produced a significant increase in perfusion pressure. This change was not modified by the addition of A-779. Losartan reduced but did not abolish this effect. Our results suggest that Ang-(1–7) produces complex vascular effects in isolated, perfused mouse hearts involving interaction of its receptor with angiotensin type 1- and type 2-related mechanisms, leading to the release of prostaglandins and nitric oxide.


Key Words: receptors, angiotensin • cardiac function • heart • angiotensin antagonist • prostaglandins